Carrier and linker technology for targeted delivery of RNAi
Bubendorf, Switzerland, Tuesday, January 24, 2023 – CIS Pharma engages additional resources in 2023 to develop a novel linker/carrier system to conjugate ASO and siRNA for targeted delivery. To [...]